BioSpace News Archive

Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced two posters will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2024.

Vivos Therapeutics, Inc. announced it plans to release its fourth quarter and full year 2023 financial results after market close today, Thursday, March 28, 2024.

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced positive, primary results up to Day 91 for its Phase II exploratory STARGAZE trial evaluating apraglutide in patients with steroid-refractory gastrointestinal acute Graft-versus-Host Disease (SR GI aGVHD).

Aeterna Zentaris Inc. and Ceapro Inc. are pleased to announce that the Court of King’s Bench of Alberta has issued a final order approving the arrangement described in the previously announced definitive agreement to combine the operations of Ceapro and Aeterna in an all-stock merger of equals transaction.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the 23rd Annual Needham Virtual Healthcare Conference, taking place April 8-11, 2024.

Integer Holdings Corporation announced that it plans to release financial and operational results for first quarter 2024, at 7 a.m. Central Time / 8 a.m. Eastern Time on Thursday, April 25, 2024.

Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, announces today that its CEO, Jeffrey Meckler will present a corporate overview at the MedInvest Biotech & Pharma Investor Conference.

CG Oncology, Inc. announced that three abstracts highlighting cretostimogene will be presented at the American Urological Association Annual Meeting, taking place at Henry B. González Convention Center in San Antonio, TX from May 3-6, 2024.

Agile Therapeutics, Inc. (Pink: AGRX), a women’s healthcare company, today reported financial results for the three and twelve months ended December 31, 2023 and provided a corporate update.

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares.